IsoRay, Inc. Announces Distribution Agreement with BrachySciences

February 18, 2009 |

1 min read

RICHLAND, Wash.--(BUSINESS WIRE)--IsoRay Inc. (AMEX: ISR) today announced it has signed an agreement with BrachySciences, a division of Biocompatibles International plc (LSE: BII), to distribute IsoRay’s Proxcelan Cesium-131 brachytherapy seeds.

Alliances

MORE ON THIS TOPIC

3D. The Red rocket that soars high and different than other rockets. Startup business successful concept.

Mergers & acquisitions

Lilly Validates Gene Editing Space With $1.3B Verve Buy, But Analysts Are Skeptical

June 17, 2025

·

3 min read

·

Annalee Armstrong

Composite photo collage of hands hold money income chip casino jackpot exchange poker game profit usd isolated on painted background.

Mergers & acquisitions

A String of Biopharma Deals Has Piqued Analyst Interest in an M&A Return

June 17, 2025

·

3 min read

·

Annalee Armstrong

Business concept illustration of a businessman digging and mining to find treasure

Antibody-drug conjugate (ADC)

NextCure Joins China-ADC Gold Rush with $745M Simcere Deal

June 16, 2025

·

1 min read

·

Dan Samorodnitsky

From left to right: Jeff Quillen, Foley Hoag; Jim Cirenza, DNB Bank; Andrew Meadow, Health Innovation Capital; Greg Benning, Back Bay Life Science Advisors; Jonathan Gertler, Back Bay Life Science Advisors

Collaboration

Partner-Seeking Biotechs Find Plenty of Hands To Shake as BIO2025 Kicks Off

June 16, 2025

·

2 min read

·